Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with<sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with¹⁷⁷Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis

Published:2023-09-07 Issue:11 Volume:64 Page:1737-1743
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Murthy Vishnu,Gafita Andrei,Thin Pan,Nguyen Kathleen,Grogan Tristan,Shen John,Drakaki Alexandra,Rettig Matthew,Czernin Johannes,Calais Jeremie

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference19 articles.

1. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

2. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

3. Hennrich U Eder M . [68Ga]Ga-PSMA-11: The first FDA-approved 68Ga-radiopharmaceutical for PET imaging of prostate cancer. Pharmaceuticals (Basel). 2021;14:713.

4. Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study

5. Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA-based therapeutics for prostate cancer;Expert Opinion on Pharmacotherapy;2024-07-02

2. RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer;Journal of Nuclear Medicine;2024-04-18

3. Impact of PSMA PET on Prostate Cancer Management;Current Treatment Options in Oncology;2024-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3